BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 16081270)

  • 1. Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals.
    Henning SM; Niu Y; Liu Y; Lee NH; Hara Y; Thames GD; Minutti RR; Carpenter CL; Wang H; Heber D
    J Nutr Biochem; 2005 Oct; 16(10):610-6. PubMed ID: 16081270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
    Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
    Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals.
    Chow HH; Cai Y; Hakim IA; Crowell JA; Shahi F; Brooks CA; Dorr RT; Hara Y; Alberts DS
    Clin Cancer Res; 2003 Aug; 9(9):3312-9. PubMed ID: 12960117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers.
    Xu JZ; Yeung SY; Chang Q; Huang Y; Chen ZY
    Br J Nutr; 2004 Jun; 91(6):873-81. PubMed ID: 15182391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability.
    Lee MJ; Maliakal P; Chen L; Meng X; Bondoc FY; Prabhu S; Lambert G; Mohr S; Yang CS
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1025-32. PubMed ID: 12376503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
    James KD; Forester SC; Lambert JD
    Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement.
    Henning SM; Niu Y; Lee NH; Thames GD; Minutti RR; Wang H; Go VL; Heber D
    Am J Clin Nutr; 2004 Dec; 80(6):1558-64. PubMed ID: 15585768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relation between single/double or repeated tea catechin ingestions and plasma antioxidant activity in humans.
    Kimura M; Umegaki K; Kasuya Y; Sugisawa A; Higuchi M
    Eur J Clin Nutr; 2002 Dec; 56(12):1186-93. PubMed ID: 12494303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma.
    Nakagawa K; Okuda S; Miyazawa T
    Biosci Biotechnol Biochem; 1997 Dec; 61(12):1981-5. PubMed ID: 9438978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of co-administration of tea epigallocatechin-3-gallate (EGCG) and caffeine on absorption and metabolism of EGCG in humans.
    Nakagawa K; Nakayama K; Nakamura M; Sookwong P; Tsuduki T; Niino H; Kimura F; Miyazawa T
    Biosci Biotechnol Biochem; 2009 Sep; 73(9):2014-7. PubMed ID: 19734672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities.
    Elbling L; Weiss RM; Teufelhofer O; Uhl M; Knasmueller S; Schulte-Hermann R; Berger W; Micksche M
    FASEB J; 2005 May; 19(7):807-9. PubMed ID: 15738004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, tissue distribution and elimination of 4-[(3)h]-epigallocatechin gallate in beagle dogs.
    Swezey RR; Aldridge DE; LeValley SE; Crowell JA; Hara Y; Green CE
    Int J Toxicol; 2003; 22(3):187-93. PubMed ID: 12851151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.
    Pandit AP; Joshi SR; Dalal PS; Patole VC
    BMC Complement Altern Med; 2019 Jun; 19(1):129. PubMed ID: 31196040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat.
    Nakagawa K; Miyazawa T
    J Nutr Sci Vitaminol (Tokyo); 1997 Dec; 43(6):679-84. PubMed ID: 9530620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Green Tea and Bone Marrow Transplantation: From Antioxidant Activity to Enzymatic and Multidrug-resistance Modulation.
    Peluso I; Palmery M; Vitalone A
    Crit Rev Food Sci Nutr; 2016 Oct; 56(14):2251-60. PubMed ID: 26047551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemiluminescence-high-performance liquid chromatographic determination of tea catechin, (-)-epigallocatechin 3-gallate, at picomole levels in rat and human plasma.
    Nakagawa K; Miyazawa T
    Anal Biochem; 1997 May; 248(1):41-9. PubMed ID: 9177723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of human glutathione s-transferases by polyphenon e intervention.
    Chow HH; Hakim IA; Vining DR; Crowell JA; Tome ME; Ranger-Moore J; Cordova CA; Mikhael DM; Briehl MM; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1662-6. PubMed ID: 17684143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tea phenols in bulk and nanoparticle form modify DNA damage in human lymphocytes from colon cancer patients and healthy individuals treated in vitro with platinum-based chemotherapeutic drugs.
    Alotaibi A; Bhatnagar P; Najafzadeh M; Gupta KC; Anderson D
    Nanomedicine (Lond); 2013 Mar; 8(3):389-401. PubMed ID: 22943128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green tea extract and its major constituent epigallocatechin-3-gallate inhibit growth and halitosis-related properties of Solobacterium moorei.
    Morin MP; Bedran TB; Fournier-Larente J; Haas B; Azelmat J; Grenier D
    BMC Complement Altern Med; 2015 Mar; 15():48. PubMed ID: 25880992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.